Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Hits New 1-Year High – Here’s What Happened

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) hit a new 52-week high during mid-day trading on Monday . The company traded as high as $9.27 and last traded at $9.0880, with a volume of 3263 shares. The stock had previously closed at $9.02.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 1.2%

The company has a quick ratio of 5.74, a current ratio of 6.44 and a debt-to-equity ratio of 0.01. The company’s 50-day moving average is $8.61 and its 200 day moving average is $8.61. The company has a market cap of $15.53 billion, a price-to-earnings ratio of 14.27, a price-to-earnings-growth ratio of 1.88 and a beta of 0.19.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its earnings results on Monday, October 27th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.02. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 39.53% and a return on equity of 11.90%. The business had revenue of $740.85 million for the quarter, compared to analyst estimates of $742.35 million. Research analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 EPS for the current year.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.